Peripheral Vascular Disease in Women: Therapeutic Options in 2019

被引:3
|
作者
Saati, Ammar [1 ]
AlHajri, Noora [2 ]
Yaqoub, Lina [3 ]
Ahmed, Waqar [4 ]
Alasnag, Mirvat [4 ]
机构
[1] Kent Hosp, Providence, RI USA
[2] NIA, Div Cardiovasc Sci, NIH, Baltimore, MD 21224 USA
[3] Louisiana State Univ, Shreveport, LA 71105 USA
[4] King Fahd Armed Forces Hosp, Cardiac Ctr, POB 9862, Jeddah 21159, Saudi Arabia
关键词
Peripheral vascular disease; Women; Endovascular revascularization; Surgery;
D O I
10.1007/s11936-019-0769-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review In recent years, there have been advances in the prevention, management, and control of peripheral vascular disease (PVD). There is a trend towards aggressive risk factor modification, noninvasive screening, and endovascular revascularization with surgical approaches reserved only for select cases. This article reviews the different management strategies ranging from pharmacotherapy, revascularization, and rehabilitation with an emphasis on the response of women to these therapies. Recent findings Overall, the representation of women in the majority of the published data in this arena remains poor. Studies examining medical therapy and endovascular and surgical revascularization were not designed to address sex disparities. Nevertheless, we dissect these therapies and their relevant randomized trials. The paucity of data investigating the response of women to the different management options makes it difficult to make any evidence-based recommendations. This not only applies to the type of intervention, but also the appropriate timing and risks entailed.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Optimal therapeutic strategy for those with chronic kidney disease and peripheral artery disease receiving peripheral vascular intervention
    Imamura, Teruhiko
    CLINICAL CARDIOLOGY, 2020, 43 (12) : 1348 - 1348
  • [22] Therapeutic options in peripheral T cell lymphoma
    Zhang, Yaping
    Xu, Wei
    Liu, Hong
    Li, Jianyong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2016, 9
  • [23] Diagnosis and therapeutic options for peripheral vasculitic neuropathy
    Blaes, Franz
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2015, 7 (02) : 45 - 55
  • [24] Therapeutic options in peripheral T cell lymphoma
    Yaping Zhang
    Wei Xu
    Hong Liu
    Jianyong Li
    Journal of Hematology & Oncology, 9
  • [25] Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
    Bae, Esther Y.
    Sanders, James M.
    Johns, Meagan L.
    Lin, Kevin
    Ortwine, Jessica K.
    Wei, Wenjing
    Mang, Norman S.
    Cutrell, James B.
    CURRENT INFECTIOUS DISEASE REPORTS, 2021, 23 (12)
  • [26] New insights on potential therapeutic options and vaccines for corona virus disease-2019
    Wayah, Samson Baranzan
    Auta, Richard
    Waziri, Peter Maitalata
    Haruna, Emmanuel
    REVIEWS IN MEDICAL MICROBIOLOGY, 2021, 32 (02) : 67 - 74
  • [27] Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
    Esther Y. Golnabi
    James M. Sanders
    Meagan L. Johns
    Kevin Lin
    Jessica K. Ortwine
    Wenjing Wei
    Norman S. Mang
    James B. Cutrell
    Current Infectious Disease Reports, 2021, 23
  • [28] Pompe disease and therapeutic options
    Raben, Nina
    Fukuda, Tokiko
    Plotz, Paul
    NEUROMUSCULAR DISORDERS, 2006, 16 : S192 - S192
  • [29] Therapeutic options in pulmonary hepatic vascular diseases
    Horvatits, Thomas
    Fuhrmann, Valentin
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (01) : 31 - 42
  • [30] Mild homocysteinaemia in patients with peripheral arterial occlusive disease: Diagnosis, incidence and therapeutic options
    Feussner, A
    Weiss, N
    Keller, C
    Wolfram, G
    ATHEROSCLEROSIS, 1997, 129 (01) : 38 - 38